Q1 2026 Holdings
Filed 2026-05-15 | 22 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $168.5M | 5,350,000 | 13.7% |
| Brookfield Corp(BN) | CL A LTD VT SH | 11271J107 | $141.5M | 3,496,245 | 11.5% |
| Asml Holding N V(ASML) | N Y REGISTRY SHS | N07059210 | $125.4M | 94,946 | 10.2% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $122.4M | 1,325,000 | 9.9% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $74.9M | 3,686,622 | 6.1% |
| Salesforce Inc(CRM) | COM | 79466L302 | $73.4M | 393,187 | 5.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $56.3M | 1,550,000 | 4.6% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $50.2M | 1,280,000 | 4.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $50.0M | 860,000 | 4.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $49.4M | 1,750,000 | 4.0% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $44.8M | 1,942,142 | 3.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $39.1M | 2,000,000 | 3.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $38.1M | 1,200,000 | 3.1% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $37.9M | 450,000 | 3.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $37.3M | 660,000 | 3.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $34.0M | 3,650,737 | 2.8% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $32.3M | 257,327 | 2.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $28.2M | 485,438 | 2.3% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $19.6M | 2,185,923 | 1.6% |
| Valneva SE(VALN) | SPONSORED ADS | 92025Y103 | $6.6M | 1,057,421 | 0.5% |
| Lanzatech Global Inc(LNZA) | COM NEW | 51655R200 | $2.5M | 158,148 | 0.2% |
| Marqeta Inc(MQ) | CLASS A COM | 57142B104 | $1.8M | 441,558 | 0.1% |